Skip to main content
SpringerLink
Log in

Critical Care Management of the ACHD Patient with Heart Failure

  • Chapter
  • First Online:
Intensive Care of the Adult with Congenital Heart Disease

Part of the book series: Congenital Heart Disease in Adolescents and Adults ((CHDAA))

  • 907 Accesses

Abstract

As more patients with congenital heart disease live into adulthood, the burden of late complications of their condition, especially heart failure, will continue to increase. Clinicians currently rely on well-established guidelines based on robust clinical trials to provide evidence-based treatment for adults without congenital heart disease who are hospitalized with heart failure. The management of adult patients with congenital heart disease in heart failure, however, is less well defined, and the correct course of action may not always be apparent. The adult population of patients with congenital heart disease is a very heterogeneous group that comprises many different physiologic states and a variety of surgical repairs. Patients with systemic left ventricles will manifest with heart failure symptoms differently than patients with a single ventricle or those with a systemic right ventricle. This chapter will discuss the presentation of heart failure in varying types of adult congenital cardiac conditions and the nuanced and individualized treatments required to manage each patient successfully through an exacerbation of heart failure requiring hospitalization.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749–56.

    Article  PubMed  Google Scholar 

  2. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115(2):163–72.

    Article  PubMed  Google Scholar 

  3. Bhatt AB, Foster E, Kuehl K, Alpert J, Brabeck S, Crumb S, et al. Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation. 2015;131:1884–931. https://doi.org/10.1161/CIR.0000000000000204.

    Article  PubMed  Google Scholar 

  4. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7. https://doi.org/10.1016/j.jacc.2009.04.037.

    Article  PubMed  Google Scholar 

  5. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008;52(23):1890–947. https://doi.org/10.1016/j.jacc.2008.10.001.

    Article  Google Scholar 

  6. Baumgartner H, Bonhoeffer P, De Groot NMS, De Haan F, Deanfield JE, Galie N, et al. ESC guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J. 2010;31(23):2915–57.

    PubMed  Google Scholar 

  7. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol. 2009;53(15):e1–90. https://doi.org/10.1161/CIRCULATIONAHA.109.192065.

    Article  PubMed  Google Scholar 

  8. Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, et al. Chronic heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133:770–801.

    Article  PubMed  Google Scholar 

  9. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112(6):828–35.

    Article  PubMed  Google Scholar 

  10. Wald RM, Marie Valente A, Marelli A. Heart failure in adult congenital heart disease: emerging concepts with a focus on tetralogy of Fallot. Trends Cardiovasc Med. 2015;25(5):422–32. https://doi.org/10.1016/j.tcm.2014.11.011.

    Article  PubMed  Google Scholar 

  11. Moussa NB, Karsenty C, Pontnau F, Malekzadeh-Milani S, Boudjemline Y, Legendre A, et al. Characteristics and outcomes of heart failure-related hospitalization in adults with congenital heart disease. Arch Cardiovasc Dis. 2017;110:1–9. https://doi.org/10.1016/j.acvd.2017.01.008.

    Article  Google Scholar 

  12. Alshawabkeh LI, Opotowsky AR. Burden of heart failure in adults with congenital heart disease. Curr Heart Fail Rep. 2016;13(5):247–54. https://doi.org/10.1007/s11897-016-0301-0.

    Article  PubMed  Google Scholar 

  13. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105(10):1189–94.

    Article  PubMed  Google Scholar 

  14. Khairy P, Ionescu-Ittu R, MacKie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56(14):1149–57. https://doi.org/10.1016/j.jacc.2010.03.085.

    Article  PubMed  Google Scholar 

  15. Raissadati A, Nieminen H, Haukka J, Sairanen H, Jokinen E. Late causes of death after pediatric cardiac surgery: a 60-year population-based study. J Am Coll Cardiol. 2016;68(5):487–98.

    Article  PubMed  Google Scholar 

  16. Dinardo JA. Heart failure associated with adult congenital heart disease. Semin Cardiothorac Vasc Anesth. 2013;17(1):44–54. http://www.ncbi.nlm.nih.gov/pubmed/23264549.

    Article  PubMed  Google Scholar 

  17. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106(1):92–9.

    Article  CAS  PubMed  Google Scholar 

  18. Giannakoulas G, Dimopoulos K, Bolger AP, Tay EL, Inuzuka R, Bedard E, et al. Usefulness of natriuretic peptide levels to predict mortality in adults with congenital heart disease. Am J Cardiol. 2010;105(6):869–73. https://doi.org/10.1016/j.amjcard.2009.11.041.

    Article  CAS  PubMed  Google Scholar 

  19. Reardon LC, Williams RJ, Houser LS, Miner PD, Child JS, Aboulhosn JA. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the eisenmenger syndrome. Am J Cardiol. 2012;110(10):1523–6. https://doi.org/10.1016/j.amjcard.2012.06.061.

    Article  CAS  PubMed  Google Scholar 

  20. Lowe BS, Therrien J, Ionescu-Ittu R, Pilote L, Martucci G, Marelli AJ. Diagnosis of pulmonary hypertension in the congenital heart disease adult population: Impact on outcomes. J Am Coll Cardiol. 2011;58(5):538–46. https://doi.org/10.1016/j.jacc.2011.03.033.

    Article  PubMed  Google Scholar 

  21. Fahed AC, Roberts AE, Mital S, Lakdawala NK. Heart failure in congenital heart disease. A confluence of acquired and congenital. Heart Fail Clin. 2014;10(1):219–27.

    Article  PubMed  Google Scholar 

  22. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013;112(4):707–20.

    Article  CAS  PubMed  Google Scholar 

  23. Mcmurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail. 2012;14(8):803–69.

    Article  CAS  PubMed  Google Scholar 

  24. Budts W, Roos-Hesselink J, Rädle-Hurst T, Eicken A, McDonagh TA, Lambrinou E, et al. Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J. 2016;37(18):1419–27.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ryan TD, Jefferies JL, Wilmot I. Managing heart failure in adults with congenital heart disease. Curr Treat Options Cardiovasc Med. 2015;17(2):376.

    Article  PubMed  Google Scholar 

  26. Babu-Narayan SV, Uebing A, Davlouros PA, Kemp M, Davidson S, Dimopoulos K, et al. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention of the deleterious effects of Pulmonary Regurgitation in Adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012;154(3):299–305. https://doi.org/10.1016/j.ijcard.2010.09.057.

    Article  PubMed  Google Scholar 

  27. Dimopoulos K, Diller GP, Koltsida E, Pijuan-Domenech A, Papadopoulou SA, Babu-Narayan SV, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117(18):2320–8. https://doi.org/10.1161/CIRCULATIONAHA.107.734921.

    Article  PubMed  Google Scholar 

  28. Allan CK. Intensive care of the adult patient with congenital heart disease. Prog Cardiovasc Dis. 2011;53(4):274–80. https://doi.org/10.1016/j.pcad.2010.11.002.

    Article  PubMed  Google Scholar 

  29. Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J. 2008;29(13):1681–7.

    Article  CAS  PubMed  Google Scholar 

  30. Roy N. Critical care management of the adult patient with congenital heart disease: focus on postoperative management and outcomes. Curr Treat Options Cardiovasc Med. 2015;17(2):1–11.

    Article  Google Scholar 

  31. Krieger EV, Valente AM. Heart failure treatment in adults with congenital heart disease: where do we stand in 2014? Heart. 2014;100(17):1329–34.

    Article  PubMed  Google Scholar 

  32. Stefanescu A, Macklin EA, Lin E, Dudzinski DM, Johnson J, Kennedy KF, et al. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome. Am J Cardiol. 2014;113(5):865–70. http://www.ncbi.nlm.nih.gov/pubmed/24411285.

    Article  PubMed  Google Scholar 

  33. Pignatelli RH, McMahon CJ, Chung T, Vick GW 3rd. Role of echocardiography versus MRI for the diagnosis of congenital heart disease. Curr Opin Cardiol. 2003;18(5):357–65. http://www.ncbi.nlm.nih.gov/pubmed/12960467.

    Article  PubMed  Google Scholar 

  34. Burchill LJ, Huang J, Tretter JT, Khan AM, Crean AM, Veldtman GR, et al. Noninvasive imaging in adult congenital heart disease. Circ Res. 2017;120(6):995–1014. https://doi.org/10.1161/CIRCRESAHA.116.308983.

    Article  CAS  PubMed  Google Scholar 

  35. Warnes CA, Bhatt AB, Daniels CJ, Gillam LD, Stout KK. COCATS 4 task force 14: training in the care of adult patients with congenital heart disease. J Am Coll Cardiol. 2015;65(17):1887–98. https://doi.org/10.1016/j.jacc.2015.03.030.

    Article  PubMed  Google Scholar 

  36. Diller GP, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation. 2012;125(20):2440–6.

    Article  PubMed  Google Scholar 

  37. Kalogeropoulos AP, Deka A, Border W, Pernetz MA, Georgiopoulou VV, Kiani J, et al. Right ventricular function with standard and speckle-tracking echocardiography and clinical events in adults with D-transposition of the great arteries post atrial switch. J Am Soc Echocardiogr. 2012;25(3):304–12. https://doi.org/10.1016/j.echo.2011.12.003.

    Article  PubMed  Google Scholar 

  38. Cioccari L, Baur H-R, Berger D, Wiegand J, Takala J, Merz TM. Hemodynamic assessment of critically ill patients using a miniaturized transesophageal echocardiography probe. Crit Care. 2013;17(3):R121. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4056104&tool=pmcentrez&rendertype=abstract.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Hammoudi N, Hékimian G, Laveau F, Achkar M, Isnard R, Combes A. Three-dimensional transoesophageal echocardiography for cardiac output in critically ill patients: a pilot study of ultrasound versus the thermodilution method. Arch Cardiovasc Dis. 2017;110(1):7–13. http://linkinghub.elsevier.com/retrieve/pii/S1875213616301528.

    Article  PubMed  Google Scholar 

  40. Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J, Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J. 2010;31(7):794–805.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Inuzuka R, Diller GP, Borgia F, Benson L, Tay ELW, Alonso-Gonzalez R, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125(2):250–9.

    Article  PubMed  Google Scholar 

  42. Binanay C, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005;294(13):1625–33.

    Article  PubMed  Google Scholar 

  43. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–66.

    Article  PubMed  Google Scholar 

  44. Bradley EA, Berman D, Daniels CJ. First implantable hemodynamic monitoring device placement in single ventricle fontan anatomy. Catheter Cardiovasc Interv. 2016;88(2):248–52. https://doi.org/10.1002/ccd.26498.

    Article  PubMed  Google Scholar 

  45. Perry J, Lanzberg M, Franklin W, Webb G, Chang AC. Cardiac intensive care of the adult with congenital heart disease: basic principles in the management of common problems. World J Pediatr Congenit Heart Surg. 2011;2(3):430–44.

    Article  PubMed  Google Scholar 

  46. Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, et al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112(16):2411–6.

    Article  CAS  PubMed  Google Scholar 

  47. Doughan ARK, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99(5):704–6.

    Article  CAS  PubMed  Google Scholar 

  48. Van Der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, et al. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127(3):322–30.

    Article  PubMed  Google Scholar 

  49. Bouallal R, Godart F, Francart C, Richard A, Foucher-Hossein C, Lions C. Interest of β-blockers in patients with right ventricular systemic dysfunction. Cardiol Young. 2010;20(6):615–9.

    Article  PubMed  Google Scholar 

  50. Dos L, Pujadas S, Estruch M, Mas A, Ferreira-González I, Pijuan A, et al. Eplerenone in systemic right ventricle: double blind randomized clinical trial. the evedes study. Int J Cardiol. 2013;168(6):5167–73. https://doi.org/10.1016/j.ijcard.2013.07.163.

    Article  PubMed  Google Scholar 

  51. Norozi K, Bahlmann J, Raab B, Alpers V, Arnhold JO, Kuehne T, et al. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young. 2007;17(4):372–9. http://www.ncbi.nlm.nih.gov/pubmed/17572925.

    Article  PubMed  Google Scholar 

  52. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RMF, Lauer A, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation. 2006;114(1):48–54.

    Article  PubMed  Google Scholar 

  53. Shabanian R, Shahbaznejad L, Razaghian A, Kiani A, Rahimzadeh M, Seifirad S, et al. Sildenafil and ventriculo-arterial coupling in fontan-palliated patients: a noninvasive echocardiographic assessment. Pediatr Cardiol. 2013;34(1):129–34.

    Article  PubMed  Google Scholar 

  54. Ringel RE, Peddy SB. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease. Am J Cardiol. 2003;91(8):1031–2.

    Article  CAS  PubMed  Google Scholar 

  55. Mahle WT, Wang A, Quyyumi AA, McConnell ME, Book WM. Impact of spironolactone on endothelial function in patients with single ventricle heart. Congenit Heart Dis. 2009;4(1):12–6.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Kouatli AA, Garcia JA, Zellers TM, Weinstein EM, Mahony L. Enalapril does not enhance exercise capacity in patients after Fontan procedure. Circulation. 1997;96(5):1507–12.

    Article  CAS  PubMed  Google Scholar 

  57. Ishibashi N, Park I-S, Waragai T, Yoshikawa T, Murakami Y, Mori K, et al. Effect of carvedilol on heart failure in patients with a functionally univentricular heart. Circ J. 2011;75(6):1394–9.

    Article  CAS  PubMed  Google Scholar 

  58. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875–85.

    Article  CAS  PubMed  Google Scholar 

  59. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004. https://doi.org/10.1056/NEJMoa1409077.

    Article  CAS  PubMed  Google Scholar 

  60. Tay ELW, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, et al. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol. 2011;151(3):307–12. https://doi.org/10.1016/j.ijcard.2010.05.066.

    Article  PubMed  Google Scholar 

  61. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation. 2010;121(1):20–5.

    Article  PubMed  Google Scholar 

  62. Diller GP, Alonso-Gonzalez R, Dimopoulos K, Alvarez-Barredo M, Koo C, Kempny A, et al. Disease targeting therapies in patients with Eisenmenger syndrome: response to treatment and long-term efficiency. Int J Cardiol. 2013;167(3):840–7.

    Article  PubMed  Google Scholar 

  63. Méndez AB, Colchero T, Garcia-Picart J, Vila M, Subirana MT, Sionis A. Unusual case of new-onset heart failure due to cor triatriatum sinister. Eur J Heart Fail. 2013;15(2):237–9.

    Article  PubMed  Google Scholar 

  64. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–406. https://doi.org/10.1056/NEJMoa1009355#t=article.

    Article  CAS  PubMed  Google Scholar 

  65. Hammerstingl C, Schueler R, Malasa M, Werner N, Nickenig G. Transcatheter treatment of severe tricuspid regurgitation with the MitraClip system. Eur Heart J. 2016;37(10):849–53. https://doi.org/10.1093/eurheartj/ehv710.

    Article  PubMed  Google Scholar 

  66. Taramasso M, Pozzoli A, Guidotti A, Nietlispach F, Inderbitzin DT, Benussi S, et al. Percutaneous tricuspid valve therapies: the new frontier. Eur Heart J. 2017;38:639–47. https://doi.org/10.1093/eurheartj/ehv766.

    Article  PubMed  Google Scholar 

  67. Franzen O, von Samson P, Dodge-Khatami A, Geffert G, Baldus S. Percutaneous edge-to-edge repair of tricuspid regurgitation in congenitally corrected transposition of the great arteries. Congenit Heart Dis. 2011;6(1):57–9. http://www.ncbi.nlm.nih.gov/pubmed/21269414.

    Article  PubMed  Google Scholar 

  68. Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100(3):247–53. https://doi.org/10.1136/heartjnl-2013-304958.

    Article  PubMed  Google Scholar 

  69. Khairy P, van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Can J Cardiol. 2014;30(10):e1–63. https://doi.org/10.1016/j.cjca.2014.09.002.

    Article  PubMed  Google Scholar 

  70. Cecchin F, Frangini PA, Brown DW, Fynn-Thompson F, Alexander ME, Triedman JK, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20(1):58–65.

    Article  PubMed  Google Scholar 

  71. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46(12):2277–83. https://doi.org/10.1016/j.jacc.2005.05.096.

    Article  PubMed  Google Scholar 

  72. Janousek J, Gebauer RA, Abdul-Khaliq H, Turner M, Kornyei L, Grollmuss O, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95(14):1165–71. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2699215&tool=pmcentrez&rendertype=abstract.

    Article  CAS  PubMed  Google Scholar 

  73. Lindsay I, Moore JP. Cardiac arrhythmias in adults with congenital heart disease: scope, specific problems, and management. Curr Treat Options Cardiovasc Med. 2015;17(12):56.

    Article  PubMed  Google Scholar 

  74. Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: Impact of ventricular assist devices. J Heart Lung Transplant. 2013;32(11):1059–64. https://doi.org/10.1016/j.healun.2013.06.024.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Shah NR, Lam WW, Rodriguez FH, Ermis PR, Simpson L, Frazier OH, et al. Clinical outcomes after ventricular assist device implantation in adults with complex congenital heart disease. J Heart Lung Transplant. 2013;32(6):1–6. http://www.ncbi.nlm.nih.gov/pubmed/23540399.

    Article  Google Scholar 

  76. Burchill LJ. Heart transplantation in adult congenital heart disease. Heart. 2016;102(23):1871–7. http://www.ncbi.nlm.nih.gov/pubmed/27836946.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Pediatric Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA

    Leigh Christopher Reardon

  2. Department of Medicine and Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA

    Leigh Christopher Reardon & Weiyi Tan

  3. Division of Cardiology, Department of Medicine, Ahmanson/UCLA Cardiomyopathy Center, David Geffen School of Medicine, Los Angeles, CA, USA

    Eugene Depasquale

Authors
  1. Leigh Christopher Reardon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eugene Depasquale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weiyi Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leigh Christopher Reardon .

Editor information

Editors and Affiliations

  1. Children’s Hospital Colorado, University of Colorado Denver, Aurora, CO, USA

    Eduardo da Cruz

  2. Pediatric Intensive Care, Royal Brompton & Harefield NHS Foundation Trust, London, UK

    Duncan Macrae

  3. Adult Congenital Heart Program, Heart Institute, Cincinnati Children Hospital Medical Center, Cincinnati, OH, USA

    Gary Webb

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reardon, L.C., Depasquale, E., Tan, W. (2019). Critical Care Management of the ACHD Patient with Heart Failure. In: da Cruz, E., Macrae, D., Webb, G. (eds) Intensive Care of the Adult with Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-94171-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94171-4_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94170-7

  • Online ISBN: 978-3-319-94171-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation